Latest broker research reports from Rudra Shares and Stock Brokers Ltd buy, sell, hold, neutral recommendations along with
share price targets forecast and upside.
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
Company is focusing on the backward and forward integration to add value to its operations and yield better performance, enabling company to become cost competitive. This is giving the cost benefits not only by reducing cost of the intermediates, which otherwise it would have purchased from the market, but also enhance margins on APIs that are developed by using these in-house manufactured intermediates. This initiative by the Company will go a long way in improving its EBITDA margins and net profits of the Company and provide a strong foundation to its operations....
One of India's leading providers of human resource services in the organized segment. It's staffing business accounts for 98% of the revenues while HR services accounts for the balance. Top-line growth will come from both the general staffing and the IT staffing vertical. But obviously the volume play is in the general staffing side. Look at margins the general staffing margin improvement is there is because of economies of scale and IT staffing vertical will overall because of a higher margin play improve the margin realization even with lower number. Sector converting into organized sector Lower penetration levels suggest huge growth potential Penetration level of flexi-staffing industry is lower in India as compared to developed regions like UK,...
With this acquisition, Excel crop would benefit in near term as global players are looking at India to increase their market share, add to their product portfolio, and strengthen their supply base in specialty and agrochemicals. Additionally, as a part of the strategic direction, it has decided to focus on speciality chemicals, pharma intermediates, pharma actives, performance chemicals and environment and biotech products as a primary focus for its future activities. Combining of ECCL's strong manufacturing capabilities along with SCC's world class research capabilities will take the company to greater heights. In addition to the company, Indian farmers will also stand benefited due to access to world renowned technologies and products and would lead...
Company focuses on the following four growth strategies to attain perpetual sustainable development. PPAP Sales have been in line with the market conditions. Unrelenting focus on building internal efficiencies in operations, as well as, capital usage has assisted the improved performance. Customer portfolio has been further expanded with the addition of Suzuki Motorcycles thereby...
NSEL has successfully consolidated its position, as a technology leader in Japan, the Middle East, Africa and South East Asian markets. Company caters to customers all across the globe having an 74% revenue derived from overseas & remaining 26% from India during September quarter FY 2017. India has contributed in Q2 by almost ` 25 crores as against ` 22 crores in the previous quarter and in the same quarter last year it was around ` 14 crores. There has been also some of the new contracts that company have in previous quarters, in the cloud as well as some of the leading banks that has contributed to growth in India. Along with that, focus on new product came in, company wanted to have in the market where they are leaders and pioneers in its software, that's the reason for this initial growth & hope to see...
Product launch and innovation - improve profitability & return ratio Company witnessed modest growth in the milk and milk products due to the rural demand and the delay ramped up in the sale side of the Diwali festival. However, witnessed a good transaction and sale improvement in important products category like cheese, whey, proteins, beverages, etc. During Q2 FY 2017, company also launched Spice Up, the new range of the cheese slice. It has a mix of the three slices with different flavors like Achari, Kacha Aam, Piri Piri & Schezwan and green chutney. Pace of new launches to increase from 4QFY17 onwards Launched new brand of dairy whitener, Milk rich, into the market with distinct packaging. 'Milk Rich'...
Company continued its strategy to focus and grow in niche segments for improved long term growth and margins. During the year, the Company divested its investments in Applied Clinical Intelligence and TAKE Business Cloud. It also made a strategic acquisition of Ecron Acunova in the last quarter of FY 2016 to further strengthen its offerings in life science domain. Acquisition of Ecron Acunova- Bodes well for company to increase its addressable market size Currently TAKE is providing functional services and software solutions related to clinical data management, regulatory compliance and drug safety, which constitutes just 35% of the pharma R&D; outsourcing. Prior to acquisition of EA, it had marginal presence in clinical trial studies, which is 60% of...
NSEL has successfully consolidated its position, as a technology leader in Japan, the Middle East, Africa and South East Asian markets. Company caters to customers all across the globe having an 74% revenue derived from overseas & remaining 26% from India during September quarter FY 2017. India has contributed in Q2 by almost ` 25 crores as against ` 22 crores in the previous quarter and in the same quarter last year it was around ` 14 crores. There has been also some of the new contracts that company have in previous quarters, in the cloud as well as some of the leading banks that has contributed to growth in India. Along with that, focus on new product came in, company wanted to have in the market where they are leaders and pioneers in its software, that's the reason for this initial growth & hope to see...
Strong asset quality with reduction in NNPA PFS is dealing with all the NPAs in the stress accounts, in fact is in the process of churning them out. The amount of gross NPA for Q2 FY17 stood at ` 403.86 crores as against ` 528.89 crores during the previous quarter of FY17. The % of gross & Net NPA to advances decreased to 4.29% & 2.86% respectively during Q2 as against 5.83% & 4.53% in the previous quarter. During Q1 FY17, PFS has been specified as a "Financial Institution" under the SARFAESI Act,2002. This would enable PFS to take effective measures related to recovery of dues/loan amount & restoration of economic value of stressed assets....
The financial performance during the year under reference has been highly impressive in terms of sales and profitability which was mainly due to moderate price levels of raw materials and packing materials throughout the year and better realizations for the company's products....